Increased alveolar nitric oxide concentration and high levels of leukotriene B4 and 8-isoprostane in exhaled breath condensate in patients with asbestosis
Open Access
- 27 February 2007
- Vol. 62 (7), 602-607
- https://doi.org/10.1136/thx.2006.067868
Abstract
Background: Inhaled asbestos fibres can cause inflammation and fibrosis in the lungs called asbestosis. However, there are no non-invasive means to assess and follow the severity of the inflammation. Exhaled nitric oxide (NO) measured at multiple exhalation flow rates can be used to assess the alveolar NO concentration and bronchial NO flux, which reflect inflammation in the lung parenchyma and airways, respectively. The aim of the present study was to investigate whether exhaled NO or markers in exhaled breath condensate could be used to assess inflammation in asbestosis. Methods: Exhaled NO and inflammatory markers (leukotriene B4 and 8-isoprostane) in exhaled breath condensate were measured in 15 non-smoking patients with asbestosis and in 15 healthy controls. Exhaled NO concentrations were measured at four constant exhalation flow rates (50, 100, 200 and 300 ml/s) and alveolar NO concentration and bronchial NO flux were calculated according to the linear model of pulmonary NO dynamics. Results: The mean (SE) alveolar NO concentration was significantly higher in patients with asbestosis than in controls (3.2 (0.4) vs 2.0 (0.2) ppb, p = 0.008). There was no difference in bronchial NO flux (0.9 (0.1) vs 0.9 (0.1) nl/s, p = 0.93) or NO concentration measured at ATS standard flow rate of 50 ml/s (20.0 (2.0) vs 19.7 (1.8) ppb, p = 0.89). Patients with asbestosis had increased levels of leukotriene B4 (39.5 (6.0) vs 15.4 (2.9) pg/ml, p = 0.002) and 8-isoprostane (33.5 (9.6) vs 11.9 (2.8) pg/ml, p = 0.048) in exhaled breath condensate and raised serum levels of C-reactive protein (2.3 (0.3) vs 1.1 (0.2) μg/ml, p = 0.003), interleukin-6 (3.5 (0.5) vs 1.7 (0.4) pg/ml, p = 0.007) and myeloperoxidase (356 (48) vs 240 (20) ng/ml, p = 0.034) compared with healthy controls. Conclusions: Patients with asbestosis have an increased alveolar NO concentration and high levels of leukotriene B4 and 8-isoprostane in exhaled breath. Measurement of exhaled NO at multiple exhalation flow rates and analysis of inflammatory markers in exhaled breath condensate are promising non-invasive means for assessing inflammation in patients with asbestosis.Keywords
This publication has 51 references indexed in Scilit:
- Fractional exhaled nitric oxide concentration is increased in asbestosis and pleural plaquesRespirology, 2006
- Peripheral Inflammation in Patients with Asthmatic Symptoms but Normal Lung FunctionJournal of Asthma, 2005
- Occupational respiratory disease in miningOccupational Medicine, 2004
- Modeling pulmonary nitric oxide exchangeJournal of Applied Physiology, 2004
- Both inflammation and remodeling influence nitric oxide output in children with refractory asthmaJournal of Allergy and Clinical Immunology, 2004
- Airway diffusing capacity of nitric oxide and steroid therapy in asthmaJournal of Applied Physiology, 2004
- Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPDThorax, 2003
- Early Inflammatory Response to Asbestos Exposure in Rat and Hamster Lungs: Role of Inducible Nitric Oxide SynthaseToxicology and Applied Pharmacology, 2002
- Nitric oxide synthases: structure, function and inhibitionBiochemical Journal, 2001
- Increased nitric oxide in exhaled air of asthmatic patientsThe Lancet, 1994